SCM
CDNA icon

Soleus Capital Management’s CareDx CDNA Stock Holding History

Soleus Capital Management’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-126,661
Closed -$8.03M – 73
2021
Q3 		$8.03M Buy
126,661
+97,361
+332% +$7.41M 1.25% 25
2021
Q2 		$2.68M Buy
+29,300
New +$2.33M 0.41% 44

Other funds holding CDNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Soleus Capital Management's CDNA Position: Q4 2021 in Review

Soleus Capital Management sold out of CareDx (CDNA) in Q4 2021, closing a stake of 126,661 shares — an estimated $8.03M sold.

Soleus Capital Management first reported a position in CDNA in Q2 2021 and held it in 2 quarters. The position peaked at $8.03M in Q3 2021. 224 funds tracked by Wall St. Rank hold CDNA as of Q4 2021.

  • Soleus Capital Management reported no remaining CareDx position as of Q4 2021 after selling out during the quarter.
  • Soleus Capital Management sold 126,661 CareDx shares in Q4 2021, an estimated $8.03M.
  • Soleus Capital Management first reported a position in CareDx in Q2 2021 and held it in 2 quarters.
  • Soleus Capital Management's CareDx position peaked at $8.03M in Q3 2021.
  • 224 funds tracked by Wall St. Rank held CareDx as of Q4 2021.

Based on Soleus Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.